TF and cancer: The levels of anti-TF IgG in cancer patients and both controls were very similar and were decreased only in patients with advanced cancer: mean O.D. = 0.50 ± 0.05 (SE) and 0.36 ± 0.05 (stage 4), P = 0.018 compared to healthy donors.